Feeds

Drug trial guinea pig faces new medical battle

Diagnosed with cancer

High performance access to file storage

One of the victims of the disastrous drug trial at Northwick Park Hospital earlier this year says he has now been diagnosed with the early stages of cancer.

The disease is attacking New Zealander David Oakley's lymphatic system, part of the immune system. He told The BBC: "It's an early sign of cancer. The best I could actually get was that if we catch it early enough it is treatable."

Six men who were hospitalised by TGN1412, an experimental treatment designed to combat immune conditions such as arthritis and multiple sclerosis, along with certain forms of leukaemia.

But instead of damping down the immune system, the compound over-stimulated it, causing the massive swelling which prompted one woman to describe her boyfriend as looking like "The Elephant Man".

After the tests went badly wrong, the men were warned they could face developing cancer, though there is no proof the trial caused Mr Oakley's condition.

An inquiry by the Medicines and Healthcare products Regulatory Authority found the trial operator Parexel had not liased properly with the drug's German developers TeGenero.

The volunteers' lawyers are currently seeking greater compensation than the initial £5,000 they were offered in April. ®

High performance access to file storage

More from The Register

next story
Fancy joining Reg hack on quid-a-day challenge?
Recruiting now for charity starvation diet
Red-faced LOHAN team 'fesses up in blown SPEARS fuse fiasco
Standing in the corner, big pointy 'D' hats
KILLER SPONGES menacing California coastline
Surfers are safe, crustaceans less so
Opportunity selfie: Martian winds have given the spunky ol' rover a spring cleaning
Power levels up 70 per cent as the rover keeps on truckin'
Discovery time for 200m WONDER MATERIALS shaved from 4 MILLENNIA... to 4 years
Alloy, Alloy: Boffins in speed-classification breakthrough
Elon Musk's LEAKY THRUSTER gas stalls Space Station supply run
Helium seeps from Falcon 9 first stage, delays new legs for NASA robonaut
Top Secret US payload launched into space successfully
Clandestine NRO spacecraft sets off on its unknown mission
prev story

Whitepapers

Top three mobile application threats
Learn about three of the top mobile application security threats facing businesses today and recommendations on how to mitigate the risk.
Combat fraud and increase customer satisfaction
Based on their experience using HP ArcSight Enterprise Security Manager for IT security operations, Finansbank moved to HP ArcSight ESM for fraud management.
The benefits of software based PBX
Why you should break free from your proprietary PBX and how to leverage your existing server hardware.
Five 3D headsets to be won!
We were so impressed by the Durovis Dive headset we’ve asked the company to give some away to Reg readers.
SANS - Survey on application security programs
In this whitepaper learn about the state of application security programs and practices of 488 surveyed respondents, and discover how mature and effective these programs are.